|
FAM173B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88657986402541E-15 |
| Normal-vs-Stage2 |
2.00599999999884E-06 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
2.587200E-01 |
| Stage1-vs-Stage3 |
1.041870E-02 |
| Stage1-vs-Stage4 |
3.969700E-04 |
| Stage2-vs-Stage3 |
8.496900E-03 |
| Stage2-vs-Stage4 |
5.442100E-04 |
| Stage3-vs-Stage4 |
1.383380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.39579999780537E-08 |
| Normal-vs-Asian |
2.68349999998918E-08 |
| Caucasian-vs-AfricanAmerican |
4.486000E-01 |
| Caucasian-vs-Asian |
1.147610E-01 |
| AfricanAmerican-vs-Asian |
1.011810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.64783808399261E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.164600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(41-60Yrs) |
2.07611705604904E-14 |
| Normal-vs-Age(61-80Yrs) |
2.05968575528459E-12 |
| Normal-vs-Age(81-100Yrs) |
1.004030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.543400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.141600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.068800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.873000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.116800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.912200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.05480000026581E-07 |
| Classical-VS-Follicular |
2.847500E-02 |
| Classical-VS-Other |
8.457800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.58779999545911E-08 |
| Tall-VS-Other |
1.159220E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
5.894400E-01 |
| Follicular-VS-Normal |
1.56539999995875E-06 |
| Other-VS-Normal |
4.043100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33146835171283E-15 |
| Normal-vs-N1 |
3.27071703054571E-13 |
| N0-vs-N1 |
3.830100E-02 |
|
|
